Skip to main content

Table 1 Instruments Considered for screening and symptom tracking for measurement based care

From: Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care

Measure

Screen or Outcome?

# of items

Time frame assessed

Self-report

References

AUDIT-C + 2

Screen

5

Past 3 months

Yes

Bradley et al. [22]

CRAFFT

Screen

9

Past year

Yes

Mitchell et al. [24]

NIDA Single Question

Screen

1

Past year

Yes

Smith et al. [25]

ASSIST-Lite

Primary & Secondary Screen

20a

Past 3 months

No

Ali et al. [26]

TAPS

Primary & Secondary Screen

4b

Past yearc

Yes

McNeely et al. [27]

DSM Checklist

Secondary Screen & Outcome

11

Variable; traditionally past year

Possible

Marsden et al. [9]

Brief Addiction Monitor (BAM)

Outcome

17

Past 30 days

Possible

Cacciola et al. [28]

Gaddy et al. [29]

Leeds Dependence Questionnaire (LDQ)

Outcome

10

Past week

Yes

Raistrick et al. [30]

Heather et al. [31]

Treatment Outcomes Profile (TOP)

Outcome

20

Past 28 days

No

Marsden et al. [32]

Treatment Effectiveness Assessment (TEA)

Outcome

4

Not specified

Yes

Ling et al. [33]

  1. aPrimary screen is 7 items; additional items asked only if primary screen for that substance is endorsed
  2. bEach item endorsed in TAPS1 leads to 2–3 follow up questions (TAPS2)
  3. cPast 3 months in TAPS2